tramadol has been researched along with glycogen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CJ; Cheng, JT; Chi, TC; Liu, IM; Lu, FH; Tzeng, TF | 1 |
Choi, SB; Jang, JS; Park, S | 1 |
2 other study(ies) available for tramadol and glycogen
Article | Year |
---|---|
Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Gluconeogenesis; Glucose; Glucose Transporter Type 4; Glycogen; Hypoglycemic Agents; Injections, Intravenous; Kinetics; Liver; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Naloxone; Narcotic Antagonists; Narcotics; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar; Receptors, Opioid, mu; RNA, Messenger; Tramadol | 2001 |
Tramadol enhances hepatic insulin sensitivity via enhancing insulin signaling cascade in the cerebral cortex and hypothalamus of 90% pancreatectomized rats.
Topics: Animals; Blood Glucose; Cells, Cultured; Cerebral Cortex; Dexamethasone; Glucokinase; Glucose; Glycogen; Hypoglycemic Agents; Hypothalamo-Hypophyseal System; Hypothalamus; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Liver; Male; Narcotic Antagonists; Narcotics; Neurosecretory Systems; Pancreatectomy; Phosphoproteins; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Signal Transduction; Tramadol | 2005 |